diabetes

Novo Nordisk's Diabetes Pill Shows Promise
Seeking Alpha
Fri, 06/27/14 - 09:37 am
diabetes
Novo Nordisk
Merrion
Emisphere
semaglutide
NN9924
Lilly Wins EU Backing for Generic of Sanofi’s Lantus
Bloomberg
Fri, 06/27/14 - 09:19 am
Europe
generics
Eli Lilly
Sanofi
Lantus
diabetes
FDA Ends Olmesartan Safety Review, But...
Forbes
Wed, 06/25/14 - 07:45 am
FDA
Olmesartan
Benicar
diabetes
Who Will Win This $45 Billion Market?
Motley Fool
Sat, 06/21/14 - 11:45 am
Sanofi
Novo Nordisk
diabetes
type 1 diabetes
type 2 diabetes
Is This MannKind's Biggest Risk?
Motley Fool
Thu, 06/19/14 - 09:22 am
MannKind
diabetes
Afrezza
Are Investors Overestimating The Market For MannKind's Afrezza?
Seeking Alpha
Mon, 06/16/14 - 08:32 pm
MannKind
diabetes
Afrezza
Sanofi May Seek Other Tie-Ups to Grow in Diabetes, Zerhouni Says
Bloomberg
Mon, 06/16/14 - 11:20 am
Sanofi
diabetes
Will These 3 Products Revolutionize Diabetes Treatment?
Motley Fool
Sun, 06/15/14 - 06:58 pm
diabetes
MannKind
Afrezza
Novo Nordisk
Apple
Novo Nordisk diabetes drug appears effective for weight loss -study
Yahoo/Reuters
Sun, 06/15/14 - 10:44 am
Novo Nordisk
obesity
diabetes
Victoza
New rivals to top diabetes drug Lantus show promise in studies
Yahoo/Reuters
Sun, 06/15/14 - 10:33 am
diabetes
Lantus
insulin
Sanofi
Toujeo
Eli Lilly
Sanofi and Medtronic team up on diabetes drug-device combination
Yahoo/Reuters
Sun, 06/15/14 - 10:06 am
Medtronic
Sanofi
diabetes
devices
MannKind Entertaining Multiple Partnership Possibilities Ahead Of FDA Decision On Afrezza
Seeking Alpha
Fri, 06/13/14 - 12:28 pm
MannKind
FDA
Afrezza
diabetes
Diabetes: The $54 billion battleground
CNBC
Fri, 06/13/14 - 12:26 pm
diabetes
Eli Lilly
Sanofi
Novo Nordisk
AstraZeneca
Obesity surgery may 'cure' diabetes for 15 years
Yahoo/AP
Wed, 06/11/14 - 10:28 am
obesity
diabetes
weight loss surgery
gastric bypass
Major Medical Organizations Establish Ambitious Diabetes Registry
Forbes
Wed, 06/11/14 - 09:04 am
diabetes
Diabetic Treatment Cost Doubles as Insulin Use Increases
Bloomberg
Tue, 06/10/14 - 08:16 pm
insulin
diabetes
Lilly's head-to-head with Victoza raises a red flag for diabetes drug dulaglutide
Fierce Biotech
Mon, 06/9/14 - 01:21 pm
Victoza
Eli Lilly
diabetes
dulaglutide
Senseonics raised $20 million for its continuous glucose monitor and hired ex-Abbott and LifeScan diabetes executive Mirasol Panlilio to lead its sales & marketing team
Mass Device
Thu, 06/5/14 - 11:51 am
diabetes
blood glucose monitoring
Senseonics
devices
The Expected Rise and Inevitable Fall of MannKind
TheStreet.com
Thu, 06/5/14 - 09:27 am
MannKind
Afrezza
diabetes
Arena Pharmaceuticals
Belviq
As Predicted, MannKind Starting Emotionally Fueled Run To FDA Approval, When It May Be Best To Go Short
Seeking Alpha
Tue, 06/3/14 - 11:02 am
FDA
diabetes
inhaled insulin
MannKind
Afrezza

Pages